LINEZOLID AN linezolid 600 mg/300 mL injection solution

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

linezolid, Quantity: 600 mg

Disponible depuis:

MedTAS Pty Ltd

DCI (Dénomination commune internationale):

Linezolid

forme pharmaceutique:

Injection, solution

Composition:

Excipient Ingredients: citric acid; glucose monohydrate; sodium hydroxide; hydrochloric acid; water for injections; sodium citrate dihydrate

Mode d'administration:

Intravenous Infusion

Unités en paquet:

10, 1

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Linezolid is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,Linezolid is active against Gram-positive bacteria only. Linezolid has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram-negative pathogen is documented or suspected.

Descriptif du produit:

Visual Identification: Clear, colourless to yellow solution, free from visible particulates; Container Type: Bag; Container Material: PE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2016-01-28